Prevalence of current tobacco use, males in Europe & Central Asia
Europe & Central Asia: Prevalence of current tobacco use, males was 30.9% in 2024. ▼ Falling
Prevalence of current tobacco use, males in Europe & Central Asia, 2000–2024
Source: Global Health Observatory Data Repository, World Health Organization (WHO). Measured in % of male adults.
Analysis
The most recent figure for prevalence of current tobacco use, males in Europe & Central Asia is 30.9%, measured in 2024. That is the lowest value across all 9 years on record.
The figure is down 1.9% on the previous year and down 14.6% over ten years.
Over the whole period, prevalence of current tobacco use, males in Europe & Central Asia peaked at 48.1% in 2000 and was at its lowest, 30.9%, in 2024.
That places Europe & Central Asia 25th out of 46 groups with data for 2024, putting it in the middle of the range.
Prevalence of current tobacco use, males in Europe & Central Asia, year by year
| Year | % of male adults | Change |
|---|---|---|
| 2000 | 48.1% | — |
| 2005 | 43.6% | -9.3% |
| 2007 | 42.0% | -3.7% |
| 2010 | 39.6% | -5.6% |
| 2015 | 36.1% | -8.8% |
| 2020 | 33.2% | -8.1% |
| 2022 | 32.0% | -3.6% |
| 2023 | 31.5% | -1.7% |
| 2024 | 30.9% | -1.9% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 44.6% | 42.0% | 48.1% | 3 |
| 2010s | 37.9% | 36.1% | 39.6% | 2 |
| 2020s | 31.9% | 30.9% | 33.2% | 4 |
Countries ranked near Europe & Central Asia
More health data for Europe & Central Asia
- Population ages 45-49, female, annual growth rate 0.9265 % change on previous year (2025)
- Population ages 45-49, male, per capita 0.0339 units per person (2025)
- Population ages 45-49, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 10-14, female, per capita 0.0299 units per person (2025)
- Population ages 45-49, male, annual growth rate 1.04 % change on previous year (2025)
- Population ages 45-49, female, per capita 0.0346 units per person (2025)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 10-14, male, annual growth rate 0.6344 % change on previous year (2025)
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, female, per capita 0.0352 units per person (2025)
Frequently asked questions
- What is prevalence of current tobacco use, males in Europe & Central Asia?
- Prevalence of current tobacco use, males in Europe & Central Asia was 30.9% in 2024, according to Global Health Observatory Data Repository, World Health Organization (WHO).
- What is the highest prevalence of current tobacco use, males recorded in Europe & Central Asia?
- The highest recorded value was 48.1% in 2000.
- What is the lowest prevalence of current tobacco use, males recorded in Europe & Central Asia?
- The lowest recorded value was 30.9% in 2024.
- How does Europe & Central Asia rank for prevalence of current tobacco use, males?
- Europe & Central Asia ranks 25th out of 46 groups with data for 2024.
- Is prevalence of current tobacco use, males rising or falling in Europe & Central Asia?
- Over the last ten years it is down 14.6%. The long-run trend across the full record is falling.
- Where does this Europe & Central Asia data come from?
- The figures come from Global Health Observatory Data Repository, World Health Organization (WHO), published as part of Prevalence of current tobacco use, males (% of male adults). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 9 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of the male population ages 15 years and over who currently use any tobacco product (smoked and/or smokeless tobacco) on a daily or non-daily basis. Tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and all forms of smokeless (oral and nasal) tobacco. Tobacco products exclude e-cigarettes (which do not contain tobacco), “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. The rates are age-standardized to the WHO Standard Population.